New Content  edit
Get The App!


CME/CE Certified On-Demand
Lecture Series

Upcoming Lectures

There are no meetings currently scheduled in this subject area.
If you are interested in this topic and would like a meeting scheduled in your local area please request a lecture by clicking the button above.

Available Topics

Treatment of Higher-Risk MDS

Program Overview:
The heterogeneity and diverse nature of the genetic mutations seen in myelodysplastic syndromes (MDS) presents challenging treatment decisions. The rapidly evolving treatment landscape provides clinicians with many new options, treatment strategies, and clinical challenges. In this program, expert faculty will use case-based examples to review, discuss and apply the latest evidence to optimize the treatment of patients with HR-MDS.

Learning Objectives
  • Describe patient characteristics which define intermediate and high-risk MDS
  • Apply the latest clinical data into patient treatment plans for patients with intermediate- and high-risk MDS

Managing Symptomatic Anemia and Improving Quality of Life in MDS

Program Overview:
Most patients with myelodysplastic syndromes (MDS) are affected by anemia and anemia-related symptoms which negatively impact health-related quality of life. As novel therapies and data continue to emerge, new treatment options and evolving clinical practice guidelines may create selection and sequencing challenges to optimizing patient outcomes. In this program, expert faculty will use case-based examples to review and discuss common clinical practice scenarios and best practices to manage anemias and improve outcomes in patients with MDS.

Learning Objectives

  • Develop therapeutic approaches/treatment plans for low- and INT-1-risk MDS to optimize longer-term care and, ultimately, patient outcomes

Accreditation Information

Joint Accreditation Statement
In support of improving patient care, these activities have been planned and implemented by the Postgraduate Institute for Medicine and Total CME.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates each live activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
Postgraduate Institute for Medicine designates each continuing education activity for 0.5 contact hour (0.05 CEUs) of the Accreditation Council for Pharmacy Education.

  • Treatment of Higher-Risk MDS - UAN: JA4008162-9999-21-3134-L01-P; 0.5 contact hour; Knowledge
  • Managing Symptomatic Anemia and Improving Quality of Life in MDS - UAN: JA4008162-9999-21-3135-L01-P; 0.5 contact hour; Knowledge
For Pharmacists: You are not eligible to receive ACPE credit if you have previously attended and received credit for any of the above listed activities.

Continuing Nursing Education
The maximum number of hours awarded for each Continuing Nursing Education activity is 0.5 contact hour.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Target Audience
These activities have been designed to meet the educational needs of physicians, registered nurses, pharmacists and other healthcare professionals involved in the care of patients with Myelodysplastic Syndromes (MDS).

Fee Information
There is no fee for these educational activities.

Jointly provided by TotalCME and Postgraduate Institute for Medicine

These activities are supported by independent educational grants from Bristol Myers Squibb and Taiho Oncology, Inc.

Available Formats

At this time, all IMPACT Live events are available as a webinar. Please check the scheduled lectures tab to register for upcoming events.

Pre-work Program/ Post-work Quiz
Live events utilize a closed-loop learning experience by providing pre-work programs and post-work quizzes to accompany the lecture events to ensure attendees of the lectures retain concepts taught. The flipped classroom pre-work episodes are developed specifically to introduce key information which may be applied during the live event and encourage engagement between the attendee and faculty. Pre-work is presented by expert faculty in several short, educational episodes. Post-work quizzes allow attendees to revisit topics for a better long-term retention and test their knowledge on concepts taught at the lecture.


Guillermo Garcia-Manero, MD
Department of Leukemia
MD Anderson Cancer Center
University of Texas
Houston, TX

Rami Komrokji, MD
Senior Member, Vice Chair, Department of Malignant Hematology
Section Head, Leukemia and MDS
Moffitt Cancer Center
Professor of Oncologic Sciences
University of South Florida
Tampa, FL